Enzo Biochem is an integrated diagnostics, clinical lab, and life sciences company. Co.'s operating segments include: Enzo Clinical Lab, which is a clinical reference laboratory providing a range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies; Enzo Life Sciences, which manufactures, develops and markets products and tools for clinical research, drug development and bioscience research customers; and Enzo Therapeutics, which is a biopharmaceutical venture that has developed multiple approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases, various of which are derived from the work of Enzo Life Sciences. We show 57 historical shares outstanding datapoints in our coverage of ENZ's shares outstanding history.
Understanding the changing numbers of ENZ shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like ENZ versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching ENZ by allowing them to research ENZ shares outstanding history
as well as any other stock in our coverage universe. |
Free ENZ Email Alerts:
Video: Shares Outstanding Importance
